The newest form of treatment for Gaucher disease is enzyme replacement therapy, in which GC can be administered intravenously. The enzyme can be prepared either by purification from placentas (alglucerase) or by.

Enzyme replacement therapy to treat Fabry's disease is currently being explored.

yes it is. however fabrazyme (enzyme replacement therapy) can stop most major damage and prolong life.

a recombinant human acid alpha-glucosidase enzyme is being used as a potential enzyme replacement therapy. This recombinant form allows scientist to make a lot of protein

Enzyme turnover is a replacement of new for 'old'.